Rare Cancer News & Clinical Trials » Trial

Trial - Adrenal Cancer (30 unread)

Functional MRI Study Reconstructed Breasts

Posted: October 11th, 2018, 2:00pm GMT

Condition: Breast Cancer
Intervention: Device: MRI scan
Sponsor: Maastricht University Medical Center
Not yet recruiting
Hématologie Adulte Prevalence of Adrenal Insufficiency Post-chemotherapy Adrenocorticotropia in Adult Hematology

Posted: September 28th, 2018, 2:00pm GMT

Condition: Haematological Malignancy
Intervention: Other: Hydrocortisone supplementation
Sponsor: Rennes University Hospital
Not yet recruiting
Exparel and Marcaine for Pain Management in Thoracoscopic Lobectomy Patients

Posted: September 24th, 2018, 2:00pm GMT

Conditions: Non Small Cell Lung Cancer; Lung Cancer Stage 1
Interventions: Drug: Liposomal Bupivacaine; Drug: Bupivacaine-Epinephrine
Sponsor: Southern Illinois University
Recruiting
The Effect of Exercise on Tumor Hypoxia in Men With Localized Prostate Cancer Undergoing Radical Prostatectomy.

Posted: September 18th, 2018, 2:00pm GMT

Condition: Prostate Cancer
Intervention: Behavioral: High Intensity Interval Training bout
Sponsor: Rigshospitalet, Denmark
Not yet recruiting
Effects of Epidural Block on the Prognosis in Patients With Pancreatic Cancer Undergoing Distal Pancreatectomy

Posted: September 6th, 2018, 2:00pm GMT

Condition: Cancer of Pancreas
Interventions: Other: GEA; Other: PCEA; Other: GA; Other: PCIA
Sponsors: Fudan University; Washington University School of Medicine
Not yet recruiting
Adrenal Artery Ablation for Primary Aldosteronism

Posted: August 31st, 2018, 2:00pm GMT

Conditions: Primary Aldosteronism; Hypertension
Interventions: Procedure: Endovascular chemical Ablation of Adrenal Gland; Drug: Sequenced antihypertensvie drugs with titrated dosage
Sponsor: Third Military Medical University
Recruiting
Cabozantinib in Advanced Adrenocortical Carcinoma

Posted: August 2nd, 2018, 2:00pm GMT

Condition: Adrenocortical Carcinoma
Intervention: Drug: Cabozantinib-s-malate
Sponsor: Wuerzburg University Hospital
Not yet recruiting
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Participants With Stage I-III Adrenocortical Cancer With High Risk of Recurrence (ADIUVO-2)

Posted: July 11th, 2018, 2:00pm GMT

Conditions: ENSAT Stage I Adrenal Cortex Carcinoma; ENSAT Stage II Adrenal Cortex Carcinoma; ENSAT Stage III Adrenal Cortex Carcinoma
Interventions: Drug: Cisplatin; Drug: Etoposide; Drug: Mitotane; Procedure: Quality-of-Life Assessment
Sponsors: M.D. Anderson Cancer Center; Amercian Australian Asian Adrenal Alliance (A5); European Network for the Study of Adrenal Tumors (ENS@T)
Recruiting
Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer

Posted: May 22nd, 2018, 2:00pm GMT

Condition: Metastatic Hormone-Sensitive Prostate Cancer
Interventions: Biological: PROSTVAC-V; Biological: PROSTVAC-F; Drug: Nivolumab; Drug: Ipilimumab; Biological: Neoantigen DNA vaccine; Device: TriGrid Delivery System; Procedure: Tumor biopsy; Procedure: Peripheral blood; Procedure: Fecal samples
Sponsors: Washington University School of Medicine; Bristol-Myers Squibb
Recruiting
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Posted: April 3rd, 2018, 2:00pm GMT

Condition: Solid Tumors
Interventions: Biological: Pembrolizumab; Drug: Standard of Care (SOC)
Sponsor: Merck Sharp & Dohme Corp.
Recruiting
A Prospective Cohort Study for Patients With Adrenal Diseases

Posted: March 22nd, 2018, 2:00pm GMT

Conditions: Adrenal Adenoma; Cushing Syndrome; Pheochromocytoma; Adrenal Incidentaloma; Adrenocortical Carcinoma; Primary Hyperaldosteronism
Intervention: Other: Hormone study and Imaging study
Sponsor: Seoul National University Hospital
Not yet recruiting
Speeding Recovery From Pain and Opioid Use

Posted: January 3rd, 2018, 3:00pm GMT

Conditions: Pain, Postoperative; Breast Cancer; Opioid Use; Surgery
Interventions: Drug: Local infiltration of bupivacaine; Drug: Pectoralis Nerve block
Sponsor: Wake Forest University Health Sciences
Not yet recruiting
Breast Cancer Screening: Digital Breast Tomosynthesis Versus Digital 2D Mammography

Posted: December 19th, 2017, 3:00pm GMT

Condition: Breast Cancer Screening
Interventions: Diagnostic Test: DBT+s2D; Diagnostic Test: 2D-FFDM
Sponsors: University Hospital Muenster; German Research Foundation
Recruiting
Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks

Posted: December 15th, 2017, 3:00pm GMT

Conditions: Adrenal Gland Neoplasm; Hypertension; Bone Diseases, Metabolic; Cardiovascular Disease; Hyperinsulinemia
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting
Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist.

Posted: December 5th, 2017, 3:00pm GMT

Condition: Prostatic Neoplasm
Interventions: Drug: Estetrol; Drug: Placebo Oral Tablet
Sponsor: Pantarhei Oncology B.V.
Recruiting
Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors

Posted: November 7th, 2017, 3:00pm GMT

Conditions: Genitourinary Cancer; Adrenocortical Carcinoma; Non-urothelial Bladder; Non-urothelial Upper Tract; Penile Cancer; Non-adenocarcinoma Prostate Cancer; Refractory Germ-cell
Interventions: Drug: Ipilimumab; Drug: Nivolumab
Sponsors: Dana-Farber Cancer Institute; Bristol-Myers Squibb
Recruiting
Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma

Posted: July 2nd, 2017, 2:00pm GMT

Conditions: Pheochromocytoma; Paraganglioma; Neuroendocrine Tumors; Neuroendocrine Neoplasms
Interventions: Drug: Lu-177-DOTATATE; Drug: Ga-68-DOTATATE; Other: F-18-FDG; Drug: Amino Acid solution
Sponsor: National Cancer Institute (NCI)
Recruiting
Cryobiopsy Versus Forceps Biopsy for Pulmonary Lesions

Posted: December 6th, 2016, 3:00pm GMT

Conditions: Solitary Pulmonary Nodule; Multiple Pulmonary Nodules
Intervention: Procedure: transbronchial biopsy
Sponsors: University of Pennsylvania; Andrew Haas; Anil Vachani; Anthony Lanfranco; Kevin Ma; Jeffrey Thompson; Edmund Moon
Recruiting
$Permalink for 'Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors'$
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

Posted: August 16th, 2016, 2:00pm GMT

Conditions: Adrenal Cortex Carcinoma; Alveolar Soft Part Sarcoma; Central Nervous System Neoplasm; Childhood Clear Cell Sarcoma of Soft Parts; Clear Cell Sarcoma of Soft Tissue; Ewing Sarcoma; Hepatoblastoma; Hepatocellular Carcinoma; MITF Positive; Osteosarcoma; Recurrent Adrenal Cortex Carcinoma; Recurrent Alveolar Soft Part Sarcoma; Recurrent Ewing Sarcoma; Recurrent Hepatoblastoma; Recurrent Hepatocellular Carcinoma; Recurrent Malignant Central Nervous System Neoplasm; Recurrent Malignant Solid Neoplasm; Recurrent Osteosarcoma; Recurrent Renal Cell Carcinoma; Recurrent Rhabdomyosarcoma; Recurrent Soft Tissue Sarcoma; Recurrent Soft Tissue Sarcoma, Excluding Rhabdomyosarcoma; Recurrent Thyroid Gland Medullary Carcinoma; Refractory Ewing Sarcoma; Refractory Malignant Central Nervous System Neoplasm; Refractory Malignant Solid Neoplasm; Refractory Osteosarcoma; Refractory Rhabdomyosarcoma; Refractory Soft Tissue Sarcoma; Refractory Soft Tissue Sarcoma, Excluding Rhabdomyosarcoma; Renal Cell Carcinoma; Rhabdomyosarcoma; Soft Tissue Sarcoma, Excluding Rhabdomyosarcoma; Solid Neoplasm; Thyroid Gland Medullary Carcinoma; Wilms Tumor
Interventions: Drug: Cabozantinib S-malate; Other: Laboratory Biomarker Analysis; Other: Pharmacological Study
Sponsor: National Cancer Institute (NCI)
Recruiting
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Posted: July 15th, 2016, 2:00pm GMT

Conditions: Acinar Cell Carcinoma; Adenoid Cystic Carcinoma; Adrenal Cortex Carcinoma; Adrenal Gland Pheochromocytoma; Anal Canal Neuroendocrine Carcinoma; Anal Canal Undifferentiated Carcinoma; Appendix Mucinous Adenocarcinoma; Bartholin Gland Transitional Cell Carcinoma; Bladder Adenocarcinoma; Cervical Adenocarcinoma; Cholangiocarcinoma; Chordoma; Colorectal Squamous Cell Carcinoma; Desmoid-Type Fibromatosis; Endometrial Transitional Cell Carcinoma; Endometrioid Adenocarcinoma; Esophageal Neuroendocrine Carcinoma; Esophageal Undifferentiated Carcinoma; Extrahepatic Bile Duct Carcinoma; Fallopian Tube Adenocarcinoma; Fallopian Tube Transitional Cell Carcinoma; Fibromyxoid Tumor; Gastric Neuroendocrine Carcinoma; Gastric Squamous Cell Carcinoma; Gastric Undifferentiated Carcinoma; Gastrointestinal Stromal Tumor; Giant Cell Carcinoma; Intestinal Neuroendocrine Carcinoma; Intrahepatic Cholangiocarcinoma; Lung Carcinoid Tumor; Lung Sarcomatoid Carcinoma; Major Salivary Gland Carcinoma; Malignant Odontogenic Neoplasm; Malignant Peripheral Nerve Sheath Tumor; Malignant Testicular Sex Cord-Stromal Tumor; Metaplastic Breast Carcinoma; Metastatic Malignant Neoplasm of Unknown Primary Origin; Minimally Invasive Lung Adenocarcinoma; Mixed Mesodermal (Mullerian) Tumor; Mucinous Adenocarcinoma; Mucinous Cystadenocarcinoma; Nasal Cavity Adenocarcinoma; Nasal Cavity Carcinoma; Nasopharyngeal Carcinoma; Nasopharyngeal Papillary Adenocarcinoma; Nasopharyngeal Undifferentiated Carcinoma; Oral Cavity Carcinoma; Oropharyngeal Undifferentiated Carcinoma; Ovarian Adenocarcinoma; Ovarian Germ Cell Tumor; Ovarian Mucinous Adenocarcinoma; Ovarian Squamous Cell Carcinoma; Ovarian Transitional Cell Carcinoma; Pancreatic Acinar Cell Carcinoma; Pancreatic Neuroendocrine Carcinoma; Paraganglioma; Paranasal Sinus Adenocarcinoma; Paranasal Sinus Carcinoma; Parathyroid Gland Carcinoma; Pituitary Gland Carcinoma; Placental Choriocarcinoma; Placental-Site Gestational Trophoblastic Tumor; Primary Peritoneal High Grade Serous Adenocarcinoma; Pseudomyxoma Peritonei; Rare Disorder; Scrotal Squamous Cell Carcinoma; Seminal Vesicle Adenocarcinoma; Seminoma; Serous Cystadenocarcinoma; Small Intestinal Adenocarcinoma; Small Intestinal Squamous Cell Carcinoma; Spindle Cell Neoplasm; Squamous Cell Carcinoma of the Penis; Teratoma With Malignant Transformation; Testicular Non-Seminomatous Germ Cell Tumor; Thyroid Gland Carcinoma; Tracheal Carcinoma; Transitional Cell Carcinoma; Ureter Adenocarcinoma; Ureter Squamous Cell Carcinoma; Urethral Adenocarcinoma; Urethral Squamous Cell Carcinoma; Vaginal Adenocarcinoma; Vaginal Squamous Cell Carcinoma, Not Otherwise Specified; Vulvar Carcinoma
Interventions: Procedure: Biospecimen Collection; Biological: Ipilimumab; Biological: Nivolumab
Sponsor: National Cancer Institute (NCI)
Recruiting
A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549

Posted: December 22nd, 2015, 3:00pm GMT

Conditions: Advanced Solid Tumors (Part A/B/C/D); Non-small Cell Lung Cancer (Part E); Melanoma (Part E); Squamous Cell Cancer of the Head and Neck (Part E); Triple Negative Breast Cancer (Part F); Adrenocortical Carcinoma (Part G); Mesothelioma (Part G); High-circulating Myeloid-derived Suppressor Cells (Part H)
Interventions: Drug: IPI-549; Drug: Nivolumab
Sponsor: Infinity Pharmaceuticals, Inc.
Recruiting
$Permalink for 'Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)'$
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Posted: June 8th, 2015, 2:00pm GMT

Conditions: Advanced Malignant Solid Neoplasm; Bladder Carcinoma; Breast Carcinoma; Cervical Carcinoma; Colon Carcinoma; Colorectal Carcinoma; Endometrial Carcinoma; Esophageal Carcinoma; Gastric Carcinoma; Glioma; Head and Neck Carcinoma; Kidney Carcinoma; Liver and Intrahepatic Bile Duct Carcinoma; Lung Carcinoma; Lymphoma; Malignant Uterine Neoplasm; Melanoma; Ovarian Carcinoma; Pancreatic Carcinoma; Plasma Cell Myeloma; Prostate Carcinoma; Rectal Carcinoma; Recurrent Bladder Carcinoma; Recurrent Breast Carcinoma; Recurrent Cervical Carcinoma; Recurrent Colon Carcinoma; Recurrent Colorectal Carcinoma; Recurrent Esophageal Carcinoma; Recurrent Gastric Carcinoma; Recurrent Glioma; Recurrent Head and Neck Carcinoma; Recurrent Liver Carcinoma; Recurrent Lung Carcinoma; Recurrent Lymphoma; Recurrent Malignant Solid Neoplasm; Recurrent Melanoma; Recurrent Ovarian Carcinoma; Recurrent Pancreatic Carcinoma; Recurrent Plasma Cell Myeloma; Recurrent Prostate Carcinoma; Recurrent Rectal Carcinoma; Recurrent Skin Carcinoma; Recurrent Thyroid Gland Carcinoma; Recurrent Uterine Corpus Carcinoma; Refractory Lymphoma; Refractory Malignant Solid Neoplasm; Refractory Plasma Cell Myeloma; Skin Carcinoma; Thyroid Gland Carcinoma; Uterine Corpus Cancer
Interventions: Drug: Adavosertib; Drug: Afatinib; Drug: Binimetinib; Drug: Capivasertib; Drug: Crizotinib; Other: Cytology Specimen Collection Procedure; Drug: Dabrafenib; Drug: Dasatinib; Drug: Defactinib; Drug: FGFR Inhibitor AZD4547; Other: Laboratory Biomarker Analysis; Drug: Larotrectinib; Biological: Nivolumab; Drug: Osimertinib; Drug: Palbociclib; Biological: Pertuzumab; Drug: PI3K-beta Inhibitor GSK2636771; Drug: Sapanisertib; Drug: Sunitinib Malate; Drug: Taselisib; Drug: Trametinib; Biological: Trastuzumab; Biological: Trastuzumab Emtansine; Drug: Vismodegib
Sponsor: National Cancer Institute (NCI)
Recruiting
USDA Western Human Nutrition Research Center (WHNRC) Cross-Sectional Nutritional Phenotyping Study

Posted: February 20th, 2015, 3:00pm GMT

Conditions: Obesity; Inflammation
Intervention:
Sponsor: USDA, Western Human Nutrition Research Center
Recruiting
Surgery of Subclinical Cortisol Secreting Adrenal Incidentalomas

Posted: February 16th, 2015, 3:00pm GMT

Condition: Adrenal Incidentalomas
Interventions: Procedure: Laparoscopic surgical removal of the adrenal tumor; Drug: Standardized medical treatment of hypertension by SAHR
Sponsor: University Hospital, Bordeaux
Recruiting
A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma

Posted: June 17th, 2013, 2:00pm GMT

Condition: Medulloblastoma
Interventions: Radiation: Craniospinal Irradiation with boost to the primary tumor site; Drug: Cyclophosphamide; Drug: Cisplatin; Drug: Vincristine; Drug: Vismodegib; Drug: Pemetrexed; Drug: Gemcitabine; Other: Aerobic Training; Other: Neurocognitive Remediation
Sponsors: St. Jude Children's Research Hospital; Genentech, Inc.; National Cancer Institute (NCI)
Recruiting
Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

Posted: November 2nd, 2009, 3:00pm GMT

Conditions: Endocrine Tumors; Thyroid Neoplasms; Parathyroid Neoplasms; Adrenal Neoplasm; Neuroblastoma
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting
Study of Adrenal Gland Tumors

Posted: June 29th, 2000, 2:00pm GMT

Condition: Adrenal Gland Neoplasm
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting
Evaluation of Patients With Endocrine-Related Conditions

Posted: May 18th, 2000, 2:00pm GMT

Conditions: Adrenal Insufficiency; Pituitary Neoplasm; Obesity
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting
Diagnosis of Pheochromocytoma

Posted: March 3rd, 2000, 3:00pm GMT

Condition: Pheochromocytoma
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting
Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex

Posted: November 4th, 1999, 3:00pm GMT

Conditions: Cushing's Syndrome; Hereditary Neoplastic Syndrome; Lentigo; Neoplasm; Testicular Neoplasm
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting

← PubMed - Adrenocortical Carcinoma Trial - Adrenocortical Carcinoma →

Rare Cancer News & Clinical Trials » Trial - Adrenal Cancer

Feeds

Trial - Adrenal Cancer (30 unread)

Posted: October 11th, 2018, 2:00pm GMT

Posted: September 28th, 2018, 2:00pm GMT

Posted: September 24th, 2018, 2:00pm GMT

Posted: September 18th, 2018, 2:00pm GMT

Posted: September 6th, 2018, 2:00pm GMT

Posted: August 31st, 2018, 2:00pm GMT

Posted: August 2nd, 2018, 2:00pm GMT

Posted: July 11th, 2018, 2:00pm GMT

Posted: May 22nd, 2018, 2:00pm GMT

Posted: April 3rd, 2018, 2:00pm GMT

Posted: March 22nd, 2018, 2:00pm GMT

Posted: January 3rd, 2018, 3:00pm GMT

Posted: December 19th, 2017, 3:00pm GMT

Posted: December 15th, 2017, 3:00pm GMT

Posted: December 5th, 2017, 3:00pm GMT

Posted: November 7th, 2017, 3:00pm GMT

Posted: July 2nd, 2017, 2:00pm GMT

Posted: December 6th, 2016, 3:00pm GMT

Posted: August 16th, 2016, 2:00pm GMT

Posted: July 15th, 2016, 2:00pm GMT

Posted: December 22nd, 2015, 3:00pm GMT

Posted: June 8th, 2015, 2:00pm GMT

Posted: February 20th, 2015, 3:00pm GMT

Posted: February 16th, 2015, 3:00pm GMT

Posted: June 17th, 2013, 2:00pm GMT

Posted: November 2nd, 2009, 3:00pm GMT

Posted: June 29th, 2000, 2:00pm GMT

Posted: May 18th, 2000, 2:00pm GMT

Posted: March 3rd, 2000, 3:00pm GMT

Posted: November 4th, 1999, 3:00pm GMT